Arrowhead Research (ARWR) Stock: Buy, Sell, or Hold?
$49.36
+0.36 (+0.73%)
▲
5d:
-19.94%
30d:
-15.09%
90d:
-42.33%
Open in Live Scanner
70/30 Portfolio Builder
Earnings: Nov 12, 2026
0d
Protect ARWR Gains
Updated Nov 11, 12:00 AM ET
QUANTITATIVE VERDICT
WAIT
LOW Confidence (58%)
Quality Score
43/100
Position
OVERSOLD
30-Day Fair Range
$54.83 – $61.92
Position: OVERSOLD
Forward P/E & Valuation
-9.9x
Next 12M consensus est.
Wall Street Target
$107.71
+118.2% upside
Options IV & Volume
HIGH Vol
HIGH volume confirmation
Support / Resistance
$46.45 / $62.00
Trend: Strong Downtrend
Executive Thesis & Bottom Line
Forward Earnings Fair Value & Price Prediction →
⏸️ WAIT FOR STABILIZATION: ARWR is down 19.9% over the last 5 days. While fundamentals may be solid, catching a falling knife is risky. Wait for price to stabilize before entering.
Get Alerted When ARWR Hits Your Target Price
Join 10,000+ traders who never miss a move
You're in! Check your email to confirm and set your target price.
100% Free
No spam, ever
Unsubscribe anytime
Interactive Price Chart (1 Month)
Loading chart...
Loading historical data...
In-depth Analysis How we analyze
Valuation Analysis: ARWR is currently trading at $49.36, which is considered oversold relative to its 30-day fair value range of $54.83 to $61.92.
Technical Outlook: Technically, ARWR is in a strong downtrend. Immediate support is located at $46.45, while resistance sits at $62.00.
Market Sentiment: ARWR scores 25/100 on our bottoming-setup gauge. Note this measures entry quality, not trend direction — a low score can mean the chart is extended after a strong run (don't chase) or still falling without stabilization; better entries typically come after a pullback toward the 20-day average. Wall Street analysts see significant upside, with an average price target of $107.71 (+118.2%). Current signals suggest waiting for a better entry point before initiating new positions.
Technical Outlook: Technically, ARWR is in a strong downtrend. Immediate support is located at $46.45, while resistance sits at $62.00.
Market Sentiment: ARWR scores 25/100 on our bottoming-setup gauge. Note this measures entry quality, not trend direction — a low score can mean the chart is extended after a strong run (don't chase) or still falling without stabilization; better entries typically come after a pullback toward the 20-day average. Wall Street analysts see significant upside, with an average price target of $107.71 (+118.2%). Current signals suggest waiting for a better entry point before initiating new positions.
Quick Decision Summary
Current Position
OVERSOLD
Historical Trading Range
$54.83 -
$61.92
Company Quality Score
43/100
(HOLD)
Volume Confirmation
HIGH
Confidence Score
57.9%
Trading Range & Key Levels
30-Day Trading Range
$54.83 -
$61.92
Current vs Trading Range
OVERSOLD
Support Level
$46.45
Resistance Level
$62.00
Current Trend
Strong Downtrend
Technical data as of
Nov 11, 2026
Protect Your Profits
Holding ARWR? Use our AI-powered strategies to protect your downside while keeping your long-term position.
View Profit Protection PlanQuantitative Signal Breakdown
- BULLISH: Price oversold vs 30-day range
- BEARISH: Weak technical setup (25/100)
- BULLISH: High volume confirmation
- BULLISH: Trading 118.2% below Wall St target ($107.71)
- WARNING: Composite score 43/100 in the bottom quintile — this cohort historically lags the market
Fundamental Context
Forward P/E (Next Year Est.)
-9.92
Wall Street Target
$107.71
(+118.2%)
Revenue Growth (YoY)
171.0%
Earnings Growth (YoY)
9.8%
Profit Margin
-47.8%
Share ARWR Analysis
Share this live ARWR analysis (with rich preview card) to Reddit, StockTwits, X, or embed the chart on your blog.
bloggers & journalists: you are free to use our charts with attribution.Reddit & Retail Trader Sentiment (ARWR)
Bullish
2 Retail Mentions
Reddit / WSB Comments
1
Bearish
StockTwits Volume
1 msgs
24h retail stream
Last Tracked
Nov 11, 2026
Daily AI digest
AI Retail Discussion Summary:
PepGen's positive trial results for myotonic dystrophy type 1 put pressure on Arrowhead Pharmaceuticals ($ARWR) due to competition in the rare-disease market.
Key Retail Themes:
Rare-disease competition
Positive trial data
Aggregated from r/wallstreetbets, r/stocks & StockTwits streams.
View All Trending Reddit & WSB Stocks →
Last updated: November 11, 2026 8:10 PM ET
Data refreshes hourly during market hours. Next update: 9:10 PM
Data refreshes hourly during market hours. Next update: 9:10 PM
🔥 Top Stocks Breaking Out Now
| Ticker | Score | Recommendation | Change % |
|---|
Technical Signals Check
Is ARWR showing a specific setup today?
Insider Activity (6 Months)
0
Buys
0
Sells
0
Net
NEUTRAL
Top Rated Biotechnology Stocks
Top-rated stocks in Biotechnology by analyst ratings.
| Stock | Analyst Consensus | Analyst Target | Tradestie Score |
|---|---|---|---|
|
CYTK
Cytokinetics Inc |
STRONG BUY
22 analysts |
$107 | 61 BUY |
|
INSM
Insmed Inc |
STRONG BUY
24 analysts |
$194 | 37 SELL |
|
MDGL
Madrigal Pharmaceuticals… |
STRONG BUY
19 analysts |
$689 | 56 HOLD |
|
CRNX
Crinetics Pharmaceutical… |
STRONG BUY
17 analysts |
$86 | 46 HOLD |
|
RCUS
Arcus Biosciences Inc |
STRONG BUY
15 analysts |
$41 | 63 BUY |
Advanced ARWR Option Strategies
Professional options setups generated by AI based on today's ARWR price and gamma walls.
Explore More Analysis & Live Quant Tools
Part A: Deep-Dive ARWR Research Pages
